Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis
- PMID: 35594838
- DOI: 10.1016/j.biomaterials.2022.121578
Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis
Abstract
Activation state of synovial macrophages is significantly correlated with disease activity and severity of rheumatoid arthritis (RA) and provides valuable clues for RA treatment. Classically activated M1 macrophages in inflamed synovial joints secrete high levels of pro-inflammatory cytokines and chemokines, resulting in bone erosion and cartilage degradation. Herein, we propose extracellular vesicle (EV)-guided in situ macrophage reprogramming toward anti-inflammatory M2 macrophages as a novel RA treatment modality based on the immunotherapeutic concept of reestablishing M1-M2 macrophage equilibrium in synovial tissue. M2 macrophage-derived EVs (M2-EVs) were able to convert activated M1 into reprogrammed M2 (RM2) macrophages with extremely high efficiency (>90%), producing a distinct protein expression pattern characteristic of anti-inflammatory M2 macrophages. In particular, M2-EVs were enriched for proteins known to be involved in the generation and migration of M2 macrophages as well as macrophage reprogramming factors, allowing for rapid and efficient driving of macrophage polarization toward M2 phenotype. After administration of M2-EVs into the joint of a collagen-induced arthritis mouse model, the synovial macrophage polarization was significantly shifted from M1 to M2 phenotype, a process that benefited greatly from the long residence time (>3 days) of M2-EVs in the joint. This superb in situ macrophage-reprogramming ability of EVs resulted in decreased joint swelling, arthritic index score and synovial inflammation, with corresponding reductions in bone erosion and articular cartilage damage and no systemic toxicity. The anti-RA effects of M2-EVs were comparable to those of the conventional disease-modifying antirheumatic drug, Methotrexate, which causes a range of toxic adverse effects, including gastrointestinal mucosal injury. Overall, our EV-guided reprogramming strategy for in situ tuning of macrophage responses holds great promise for the development of anti-inflammatory therapeutics for the treatment of various inflammatory diseases in addition to RA.
Keywords: Extracellular vesicle; Inflammation; Macrophage; Reprogramming; Rheumatoid arthritis.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
The regulation of macrophage polarization by hypoxia-PADI4 coordination in Rheumatoid arthritis.Int Immunopharmacol. 2021 Oct;99:107988. doi: 10.1016/j.intimp.2021.107988. Epub 2021 Jul 29. Int Immunopharmacol. 2021. PMID: 34333356
-
M2 Macrophage-Derived Extracellular Vesicles Encapsulated in Hyaluronic Acid Alleviate Osteoarthritis by Modulating Macrophage Polarization.ACS Biomater Sci Eng. 2024 May 13;10(5):3355-3377. doi: 10.1021/acsbiomaterials.3c01833. Epub 2024 Apr 2. ACS Biomater Sci Eng. 2024. PMID: 38563817
-
Macrophage polarization in rheumatoid arthritis: signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts.Front Immunol. 2024 May 10;15:1394108. doi: 10.3389/fimmu.2024.1394108. eCollection 2024. Front Immunol. 2024. PMID: 38799455 Free PMC article. Review.
-
Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review.Autoimmun Rev. 2019 Nov;18(11):102397. doi: 10.1016/j.autrev.2019.102397. Epub 2019 Sep 11. Autoimmun Rev. 2019. PMID: 31520798
-
The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis.Front Immunol. 2022 May 19;13:867260. doi: 10.3389/fimmu.2022.867260. eCollection 2022. Front Immunol. 2022. PMID: 35663975 Free PMC article. Review.
Cited by
-
Yin-Yang: two sides of extracellular vesicles in inflammatory diseases.J Nanobiotechnology. 2024 Aug 27;22(1):514. doi: 10.1186/s12951-024-02779-9. J Nanobiotechnology. 2024. PMID: 39192300 Review.
-
Updates on the Pathophysiology and Therapeutic Potential of Extracellular Vesicles with Focus on Exosomes in Rheumatoid Arthritis.J Inflamm Res. 2024 Jul 19;17:4811-4826. doi: 10.2147/JIR.S465653. eCollection 2024. J Inflamm Res. 2024. PMID: 39051053 Free PMC article. Review.
-
Administration of Liposomal-Based Pde3b Gene Therapy Protects Mice Against Collagen-Induced Rheumatoid Arthritis via Modulating Macrophage Polarization.Int J Nanomedicine. 2024 May 17;19:4411-4427. doi: 10.2147/IJN.S454445. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38774028 Free PMC article.
-
Ficolin-A induces macrophage polarization to a novel pro-inflammatory phenotype distinct from classical M1.Cell Commun Signal. 2024 May 15;22(1):271. doi: 10.1186/s12964-024-01571-4. Cell Commun Signal. 2024. PMID: 38750493 Free PMC article.
-
Apoptotic extracellular vesicles restore homeostasis of the articular microenvironment for the treatment of rheumatoid arthritis.Bioact Mater. 2024 Mar 4;35:564-576. doi: 10.1016/j.bioactmat.2023.11.019. eCollection 2024 May. Bioact Mater. 2024. PMID: 38469201 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical